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 Rickettsia felis is the etiologic agent of flea-borne spotted fever (FBSF) in humans and a 
poorly described cause of fever in animals. It is transmitted by its primary arthropod vector and 
reservoir host, the cat flea Ctenocephalides felis. Known routes of Rickettsia felis transmission 
between Rickettsia felis-infected cat fleas and vertebrate hosts include cutaneous bites and 
contamination of cutaneous wounds with infective flea feces. The bulk of FBSF infections occur 
in young children in Africa, though infections of people at all ages all over the world have been 
confirmed. As mammals and young children frequently come into contact with flea feces through 
routine grooming and indiscriminate oral hygiene, respectively, we speculate that ingestion of 
infective flea feces may potentially account for a portion of natural Rickettsia felis infections. To 
investigate the potential role ingestion of Rickettsia felis plays in transmission of the bacterium to 
vertebrates, we designed sister experiments using a BALB/c mouse model to determine 1) if 
Rickettsia felis could establish an infection via an oral route and 2) if Rickettsia felis could 
establish an infection via an oral route in the form of infective cat flea feces. For our first 
objective, Rickettsia felis was cultured in ISE6 cells, purified, and administered orally in SPG 
buffer. Our second objective was executed by feeding a viable Rickettsia felis-spiked blood meal 
to Ctenocephalides felis, collecting infective flea feces, and administering the feces orally in 
SPG buffer. In both experiments necropsy was performed at 1, 7, and 14 days post-exposure and 
heart, liver, spleen, stomach, and intestine were collected for DNA extraction, RNA extraction, 
and qPCR analysis. Tissues with positive results were subsequently submitted for histopathology 
using hematoxylin and eosin staining as well as anti-Rickettsia immunohistochemistry. Select 
tissues were tested via RT-qPCR and a single serum sample via an indirect immunofluorescence 
assay. Our results indicate that R. felis from culture is transmissible via ingestion in mice and 
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may be found in organs distant from the gastrointestinal tract at all time-points tested without 
evoking inflammation. Further studies are needed to characterize all aspects of R. felis 






















CHAPTER 1. THE CASE FOR INGESTION AS A POTENTIAL ROUTE 
OF RICKETTSIA FELIS INFECTION 
 
1.1. A Review of Rickettsia 
The genus Rickettsia belongs to the order Rickettsiales (phylum Proteobacteria, class 
Alphaproteobacteria) which derives from a distant ancestor that diverged from mitochondria 
after colonizing single-celled organisms 2,000-1,500 million years ago [1]. As a consequence of 
the Cambrian Explosion ushering in the majority of characteristically multicellular metazoan 
phyla, members of Rickettsiales started infecting eukaryotes, notably early arthropods, around 
525-425 million years ago [2, 3]. Rickettsia began to diverge from the closely related genus 
Orientia around 225-150 million years ago and subsequently evolved to occupy ecological 
niches as the hydra, torix, and arthropod-associated clades [2]. The former two clades are known 
parasites of many protists and leeches, however, there is debate whether the arthropod-associated 
Rickettsia initially infected protists and later adapted to infecting arthropods [2]. This theory is 
logically supported by the idea that early arthropods were exposed to Rickettsiales via ingestion 
of their protist hosts. Protists emerged far sooner than arthropods, the first multicellular protists 
as early as 1,200 million years ago [4-6], indicating a significantly longer period of co-habitation 
with Rickettsiales. Moreover, genomic sequencing of Rickettsia bellii has revealed genes related 
to amoebal symbionts, suggesting an ancient horizontal gene transfer event occurred [1, 7, 8]. 
Rickettsia first came under scientific scrutiny through the eyes of Howard Taylor 
Ricketts, an American pathologist whose 1907-1909 investigation into Rocky Mountain Spotted 
Fever led him to correctly describe the etiologic agent Rickettsia rickettsii as a pleomorphic 
bacillus isolated from the salivary glands, alimentary sac, and ovaries of ticks [9, 10]. In the 
following decades small intracellular bacteria that were unable to be isolated or otherwise 
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grouped were described as rickettsiae [1], particularly if they were gram negative, difficult to 
culture, and borne by hematophagous arthropods. Classically, Rickettsia have been placed into 
two key groups based on arthropod vector, optimal growth temperatures, antigenic 
characteristics, and clinical signs associated with disease [10-12]. These main groups include the 
spotted fever group (SFG) composed of Rickettsia species typically transmitted by ticks and the 
typhus group (TG) made up of Rickettsia species transmitted predominantly via fleas or lice [1, 
11]. With the dawn of molecular diagnostics, whole genome sequencing, gene banking, and 
computational phylogenetics, over 30 Rickettsia species and many strains have been identified 
[2, 10] and a few species erroneously classified as Rickettsia – such as Coxiella burnetti, the 
causative agent of Q fever – have been removed [10]. A landmark phylogenetic study published 
by Gillespie et al in 2007 established the transitional group (TRG) and rooted Rickettsia 
phylogeny to the ancestral group (AG), defining four distinct modern lineages of Rickettsia [8, 
13, 14]. TRG rickettsiae, consisting chiefly of Rickettsia felis, Rickettsia akari, and Rickettsia 
australis, share features of both the SFG and TG rickettsiae [1, 8, 13]. SFG rickettsiae 
demonstrate increased sequence homogeneity relative to other clades and are capable of entering 
the host cell nucleus through the polymerization of actin [1]. TG rickettsiae are partially 
characterized by highly reductive genomes [13], a common theme amongst intracellular 
symbionts as they become increasingly reliant on host metabolic pathways [3] – and increasingly 
pathogenic [1]. In contrast with the other clades, members of the basal AG are largely considered 
non-pathogenic to vertebrates [2]. 
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1.2. The Current Understanding of Rickettsia felis as an Emerging Pathogen 
1.2.1. Discovery, Characterization, and Organization 
 A minor debate persists regarding the original point of discovery of Rickettsia felis. It has 
been suggested that the organism was first described upon isolation from a European cat flea 
(Ctenocephalides felis) in 1918 by H. Sikora who named it ‘Rickettsia ctenocephali’ [15, 16] 
before it was subsequently forgotten. As this occurred prior to the molecular age, it is impossible 
to determine if the organism Sikora described was truly the modern-day R. felis or simply the 
other known flea-borne rickettsia, Rickettsia typhi [10]. Rather, the discovery is commonly 
credited to Adams et al for their 1990 electron microscopy-based description of a rickettsia-like 
organism in the midgut epithelial cells, myocytes, fat body, ovaries, and epithelial sheath of the 
testes of a laboratory cat flea colony [15, 17-22]. Ironically, the flea colony was being used to 
identify a vector for Ehrlichia risticii (renamed Neorickettsia risticii), the causative agent of 
Potomac Horse Fever [22]. This incidentally identified organism – temporarily termed ‘ELB 
agent’ for the flea supplier Elward Laboratory [17, 20-22] – was characterized as part of 
Rickettsia in 1992 by Azad et al after successful amplification of a conserved genera-specific 17-
kDa protein antigen and a citrate synthase gene (gltA) [17, 20]. Through a series of specific 
polymerase chain reaction (PCR) amplifications and restriction enzyme assays, Azad et al 
determined that ELB agent more closely resembled TG Rickettsia than SFG Rickettsia [20], a 
classification overturned in 2001 by Bouyer et al [22] who successfully demonstrated 
amplification of the SFG-associated 190-kDa antigen gene (rompA). Meanwhile, Higgins et al 
investigated eight laboratory colonies of cat fleas, identified a 43-93% prevalence range of ELB 
agent, and subsequently proposed ELB agent be deemed Rickettsia felis [17, 22-24], which was 
soon placed in the newly organized TRG [8].  
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1.2.2. Distribution and Arthropod Association 
 R. felis exhibits a worldwide distribution, with positive identification on every continent 
except for Antarctica [10, 11, 15, 17, 25, 26]. This sprawl is largely due to the nearly ubiquitous 
presence of the cat flea (Ctenocephalides felis) [17, 26, 27], which has been considered the 
primary vector of R. felis as well as its reservoir host owing to its ability to maintain the 
bacterium in flea populations [24, 25, 28]. While R. felis bears a strong relationship with the cat 
flea, it is only considered to be a facultative parasite of this species [18]. Furthermore, R. felis is 
unique among rickettsiae in that it can infect both insect and acarine arthropod hosts [17, 29-32]. 
These arthropods have come to include over 10 other flea species, several species of ticks, 
mosquitoes, mites, and chiggers, as well as a single report in a bed bug [15, 17, 25, 33, 34] and a 
single non-hematophagous host, the book louse Liposcelis bostrychophila [35-37].  
 Transmission of R. felis within cat fleas has been shown to occur both vertically and 
horizontally [19, 26, 28, 38-40]. Vertical transmission of R. felis between generations of cat fleas 
was deemed plausible when the bacterium was noted in ovaries and the epithelial sheath of testes 
[21]. In 2002 Wedincamp and Foil [28] demonstrated vertical transmission for up to 12 
generations of cat fleas, indicating that both transovarial and transstadial maintenance of R. felis 
occurs. They additionally noted that there were no negative effects of infection on host fitness, 
such as reduced egg counts [28]. They did, however, report waning levels of R. felis past the F8 
generation [28], suggesting that vertical transmission alone was unlikely to perpetually maintain 
the infection in a single flea colony [26, 41]. In a separate study, Wedincamp and Foil reported 
PCR detection of R. felis in feline blood and that laboratory cats became seropositive within four 
months of exposure to R. felis-infected cat fleas, providing additional support for horizontal 
transmission [42]. In 2008 Macaluso et al reported the presence of R. felis in the salivary glands 
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of cat fleas observed with transmission electron microscopy and confirmed via PCR [19]. 
Finally, in 2011 Hirunkanokpun et al showed that horizontal transmission between cat fleas 
occurs via both cofeeding – the sharing of a blood-meal between infected and naïve hosts –  and 
mating [38], while Reif et al demonstrated that cat fleas could become infected with R. felis via 
an infective blood meal [43]. Brown et al went further in 2015, demonstrating cofeeding 
transmission of R. felis between two different arthropod species (C. felis and Xenopsylla cheopis) 
[26]. This hints at a greater complexity of R. felis transmission that is undoubtedly occurring in 
sylvatic, suburban, and urban cycles [17]. Moreover, horizontal transmission for maintenance in 
an arthropod host has been associated with increased pathogenicity in rickettsiae [14, 44]. 
1.2.3. Intraspecific Variation and Virulence 
 Several strains of Rickettsia felis have been identified to date. R. felis was first isolated in 
pure culture from Ctenocephalides felis by Raoult et al in 2001 using a Xenopus laevis-derived 
XTC-2 cell line [45]. This cultured line, designated as R. felis str. URRWXCal2 (alternatively 
Marseille-URRWXCal2 or California 2), grew best at 28˚C and failed to grow at temperatures 
>32 ˚C – a characteristic that supported the early placement of R. felis in the SFG rickettsiae [17, 
45, 46]. In 2006 a novel isolate of R. felis str. URRWXCal2 (Pedreira) was successfully grown in 
a C6/36 Aedes albopictus cell line [47]. In the same year a new strain of R. felis, R. felis str. LSU, 
was isolated from C. felis and cultured in an ISE6 Ixodes scapularis cell line [48]. In 2010 Behar 
et al identified R. felis in a non-hematophagous booklouse, Liposcelis bostrychophila; this strain 
is not officially named and is referred to as “Aus-Lb” [37]. Similarly, R. felis str. LSU-Lb was 
isolated from the same species of booklouse and was successfully grown in ISE6 cells by 
Thepparit et al in 2011 at 32 ˚C [35]. Finally, a Rickettsia felis-like organism (RFLO) from 
Asembo, Kenya, known as Candidatus Rickettsia asemboensis, was described by Jiang et al in 
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2013 [49]. Currently, over 30 RFLOs have been identified in wild-caught arthropods worldwide 
based on 0.2% divergence of the 16S rRNA (rrs) gene [25], however, caution has been advised 
for future speciation based on low thresholds of genomic divergence [50], as phenotypic and 
ecological relevance may be insignificant [25]. 
The genome of R. felis str. URRWXCal2 was first sequenced in 2005 by Ogata et al [46, 
51]. Subsequently, Gillespie et al sequenced the genomes of R. felis str. LSU and R. felis str. 
LSU-Lb in 2014 [14]. Comparison of the genomes revealed that the cat flea-associated strains 
were minimally divergent and that the differences observed in LSU-Lb likely resulted from 
adaptation to an endosymbiotic relationship with the booklouse [14]. Interestingly, it has been 
shown that the booklouse requires R. felis for development of the oocyte, indicating a different 
type of vector association as compared to the facultative parasitic relationships of flea-borne 
rickettsiae [25, 36, 52].  
The initial team sequencing URRWXCal2 estimated the presence of ~1,500 open reading 
frames and two plasmids they named pRF and pRFδ, the first plasmids to be discovered in a 
Rickettsia species [46].  Pornwiroon et al noted that strain LSU contained pRF but lacked pRFδ 
[48], a finding later confirmed by Fournier et al who additionally discovered that strain 
URRWXCal2 may lose pRFδ at high passage [53]. Similarly, other strains of R. felis have been 
identified that occasionally lack plasmids altogether (e.g. strain RF2125) [53, 54].  Interestingly, 
strain LSU-Lb contains pRF and a unique plasmid pLbaR [14]. In order to determine the effect 
of strain (i.e. presence of pRF and pLbaR) on transmission, infection, and host fitness, Healy et 
al infected C. felis with R. felis str. LSU-Lb for comparison with R. felis str. LSU [18]. 
Surprisingly, they found that strain LSU-Lb infected C. felis more efficiently than strain LSU 
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[18], suggesting either that vector adaptation occurs despite variance in plasmids or that plasmids 
play a minor role in host relationships of R. felis strains.  
While the functions of these plasmids are still being explored, their presence and putative 
as well as confirmed genes suggests several possibilities, including potential virulence genes as 
well as release of effector molecules and horizontal gene transfer via components of a Type IV 
Secretion System [8, 14, 46, 55-57].  Although R. felis and other vertebrate-associated rickettsiae 
lack pathogenicity islands [1, 8, 58], prospective virulence genes of R. felis notably include 
several sca genes, surface antigens variably involved in adhesion and actin-based motility (sca2), 
including ompB and sca4 which have been universal among Rickettsia [46, 59-64]; a 
hyaluronidase homolog pRF56 which bears sequence homology to Clostridium perfringens 
hyaluronidase NagI  [8, 46]; pat1 and paralog pat2 potential phospholipases [8, 46, 65, 66]; and 
several genes for patatin-like proteins associated with hemolytic activity – a finding functionally 
confirmed by dithiothreitol inhibition [46]. Of these, the most concerning for higher eukaryotes 
is hyaluronidase, which is considered a “spreading factor” owing to its ability to digest the 
extracellular matrix of animal tissues [8]. Similarly, R. felis also contains a chitinase, which 
explains its ability to colonize arthropods [46]. Additionally, R. felis has several genes devoted to 
antibiotic resistance, including resistance to streptomycin, class C and D Β-lactamases, and 
penicillin [46]. Finally, pathogenicity is further implied by the reductive nature of the R. felis 
genome, which has been associated with pathogenic phenotypes [1]. It has been proposed that 
these deletions occurred either through relaxation of purifying selection [1, 67-69] or through 
failed horizontal gene transfer [1, 70], each resulting in degraded genes or pseudogenes. 
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1.2.4. Disease Association in Animals and Humans 
 While Rickettsia felis has been isolated from many arthropods, its primary vector and 
reservoir host is the cat flea [15, 25], which has been found worldwide in close association with 
vertebrates of sylvatic, suburban, and urban ecosystems. It is important to note that a definitive 
mammalian host of R. felis has yet to be identified [17] and that the bacterium has not been 
isolated from a vertebrate host [11, 25], leaving Koch’s postulates of disease causality 
unfulfilled. Furthermore, Brown et al demonstrated that horizontal transmission of R. felis occurs 
between cofeeding arthropods in the absence of bacteremia, suggesting that vertebrate 
transmission and a subsequent systemic infection are not required for maintenance of R. felis in 
arthropod hosts [26]. Consequently, the clinical significance of R. felis has been questioned [26, 
71]. Though this may be, there remains a significant body of evidence that supports the role of R. 
felis as a pathogen of both animals and humans. 
 While many companion animals are protected from hematophagous arthropods due to 
diligent owners and preventative medications, neglected, stray, and wild animals are completely 
exposed to such vectors. These animals play an important role in the health of humans as 
sentinels of infectious disease, particularly in suburban and urban settings [72]. Since being 
definitively identified in 1996, R. felis has been reported in association with mammals 
worldwide. Stray cats and dogs, opossums, raccoons, and rats are considered reservoir hosts [22, 
25]. Surveillance studies conducted in several countries have investigated the prevalence of R. 
felis in the fleas of these species with rates that are mostly in agreement with the <25% for wild-
caught fleas reported by Reif et al [38, 73-84]. Importantly, animals have been shown to mount 
an antibody response to R. felis, as first documented by Wedincamp and Foil when their research 
cats seroconverted within four months [17, 42, 85, 86], suggesting infection occurs in 
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vertebrates. Furthermore, Mongkol et al correlated R. felis with fever, anemia, and petechia in 
dogs by specifically collecting fleas and blood from dogs diagnosed with fever of unknown 
origin (FUO) [76]. While their results provide evidence of R. felis-association in these clinically 
ill dogs, it is uncertain which diagnostic tests these dogs received in order to rule-out other 
etiologies, thus further studies are needed to refine this association. Currently, no articles related 
to R. felis-associated disease in animals can be found in the Journal of the American Veterinary 
Medical Association or the American Journal of Veterinary Research, suggesting that it has 
largely been overlooked as a significant cause of concern in veterinary medicine. Likewise, R. 
felis is not mentioned in the latest edition of The Textbook of Veterinary Internal Medicine [87]. 
The diagnosis of arthropod-borne illness in veterinary medicine is largely dependent on 
microimmunofluorescence, direct immunofluorescence, and to a lesser extent serology and PCR 
identification [87], methods with potential for interspecies cross-reactivity that have not been 
fully delineated [10]. Moreover, empirical treatment is common practice in veterinary medicine, 
and, considering the treatment for most arthropod-borne illnesses is a tetracycline antibiotic – 
chiefly doxycycline – there is little pressure on practitioners to reach an absolute diagnosis. 
Furthermore, one survey of veterinarians found that only 55.8% polled knew of R. felis and only 
51.2% thought fleas posed a health risk to humans [88]. Therefore, the sparsity of hard evidence 
supporting the affiliation of R. felis with animal disease is likely due to a combination of 
effective preventative medicine against companion animal ectoparasites, a lack of need for an 
absolute diagnosis in the treatment of arthropod-borne animal disease, a paucity of correlative 




 The incidence of R. felis-associated disease is better documented in humans as compared 
to animals and has been reported worldwide, notably in several endemic areas including large 
swathes of sub-Saharan Africa, parts of Texas, and Los Angeles, California [11, 15, 89-91]. In 
humans, R. felis-related disease is termed flea-borne spotted fever (FBSF) and has been 
associated with clinical signs such as headaches, fever, chills, cough with or without pneumonia, 
malaise, and myalgia, dermatologic signs such as a maculopapular rash or eschar, and rarely 
more severe gastrointestinal or neurological signs such as photophobia, hearing loss, or 
meningitis [11, 15, 89, 92-94]; many signs that occur with murine typhus (endemic typhus) 
infections [25]. Murine typhus is caused by Rickettsia typhi and is similarly transmitted by fleas 
in regions worldwide that commonly overlap with R. felis [11]. Consequently, FBSF has likely 
been misdiagnosed as murine typhus for years [45]. Indeed, in 1994 the first confirmed human 
case of FBSF was initially misdiagnosed as murine typhus in 1991 due to poor specificity of 
serological testing for rickettsial diseases [95]. Since that time serology has improved and many 
reports have identified seropositivity in humans, providing further evidence of R. felis exposure 
and possible infection [76, 96-103]. Interestingly, a 2017 report by Teoh et al investigated the 
incidence of seropositivity in veterinarians – a unique human niche consistently exposed to fleas 
over the span of many years [88]. They found 16% of veterinarians were unequivocally positive 
for exposure to R. felis and an additional 35.1% tested were seropositive either for R. felis or R. 
tyhpi [88]. In a comical turn of biological retribution, veterinarians that failed to advocate for flea 
prevention were significantly more likely to be seropositive [88].  
Perhaps the most compelling case for zoonotic horizontal transmission of R. felis via fleas 
was reported by Richter et al in 2002, detailing a couple and their dogs [104]. The couple each 
developed a fever and maculopapular rash. A series of negative diagnostic results led physicians 
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to eventually test for flea and tick-borne diseases as the couple reported that their dogs had been 
infested with ectoparasites. Both the woman and one of her dogs had high titers for R. felis. The 
presence of R. felis was later confirmed with Western blot and PCR analyses. Although no 
ectoparasites were available from the dogs for testing, the physicians came to the logical 
conclusion that the couple had been bitten by fleas or ticks from their dogs. While no conclusion 
can be drawn regarding zoonotic horizontal transmission, the case provides solid evidence that 
domestic exposure to ectoparasites can result in human disease [104].  
In Africa fever rates have remained stagnant even though cases of malaria have declined 
[105]. In the effort to discern causes for FUO, investigators have identified R. felis as a 
significant entity in febrile children less than five years of age, especially those younger than 
three [101, 105]. Mourembou et al found that R. felis is significantly more associated with febrile 
children than afebrile children and that several febrile children presented with detectable levels 
of R. felis in their blood, suggestive of bacteremia in a situation of active infection [105]. 
Conversely, Mediannikov et al revealed that some patients bacteremic with R. felis lack an 
antibody response and that others are asymptomatic [106, 107], leading them to propose the 
possibilities of relapse or recurrent infections or that people may be reservoir hosts. Still another 
possibility to consider is cutaneous contamination during sampling, as skin swabs of African 
patients have been PCR positive for R. felis [108]. In spite of the inconsistent data surrounding 
FBSF, a group of researchers that correctly predicted the chikungunya and Zika virus outbreaks 
of the past ten years believe Aedes spp. mosquitoes transmitting R. felis out of Africa will 
account for the next global epidemic [109]. 
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1.2.5. Routes of Transmission to Vertebrates 
 The most widely accepted method for transmission of R. felis from an arthropod to a 
vertebrate is via an infectious bite. This route was presumed with initial identification of FBSF, 
further supported by seropositivity in vertebrates post flea-feeding [42], gained traction when 
Macaluso et al identified R. felis in the salivary glands of cat fleas [19], and was finally proven 
by Brown et al when R. felis transcripts were recovered from flea-feeding sites on mice skin 
[26]. Additionally, it has been suggested that contamination of cutaneous wounds (i.e. flea-
feeding sites) with infectious flea feces could constitute an alternate route of transmission, as is 
the case with Rickettsia prowazekii and Rickettsia typhi, the causative agents of epidemic typhus 
and murine typhus, respectively [110-112]. This hypothesis was supported by Reif et al who 
established that cat flea feces contains R. felis DNA as far out as 28 days post exposure (DPE) 
and additionally that the R. felis was viable, as RNA transcripts were recovered in cat flea feces 
at 21 DPE [43]. Further evidence for deposition of R. felis in cat flea feces was provided by 
Thepparit et al in 2013 when they used immunofluorescence assays and transmission electron 
microscopy to demonstrate the dissemination of R. felis into cat flea excretory organs including 
the hindgut, Malpighian tubules, and rectal ampulla [40]. Finally, this route was tested by 
Legendre et al [113] who conducted an experiment wherein mice were intradermally inoculated 
with infectious doses of R. felis from culture and flea feces. They found sites of inoculation were 
significantly positive for R. felis DNA at 24 and 48-hours post exposure, both from culture and 
infective flea feces [113]. To date, a timeline of significant milestones in research related to R. 








Figure 1. A timeline of Rickettsia felis milestones. 1A 1990s. 1B 2000s. 1C 2010s. 
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The current study seeks to further investigate the infectious nature of flea feces, 
hypothesizing infectivity of R. felis to vertebrates via ingestion, as is the case for similar 
organisms covered in the following section. Preliminary evidence of alimentary exposure to R. 
felis is provided by Keita et al who established the presence of R. felis in the feces of both apes 
and humans across Africa [114, 115], minimally suggesting exposure via ingestion and, more 
ominously, alimentary infection and the possibly of shedding of R. felis in feces – the 
implications of which would be considerable for animal and human health globally. From a 
veterinary perspective, mammalian grooming behaviors provide ample exposure to fleas and flea 
feces; indeed, Wade and Georgi demonstrated that as many as 49.5% of the fleas on a cat end up 
in its feces [116]. This route also supports the age bias in humans identified by Mourembou et al, 
as younger children – a niche of humans with poor hygiene and indiscriminate oral exposure – 
were statistically more likely to contract FBSF [105]. 
1.3. Ingestion as a Route of Infection of Similar Pathogens 
Transmission via ingestion has been observed in several other obligate and facultative 
intracellular Alphaproteobacteria. Both Neorickettsia helminthoeca and Neorickettsia risticii are 
ultimately ingested by their vertebrate hosts in which they are the causative agents of salmon 
poisoning disease and Potomac Horse Fever, respectively [117-119]. Bartonella henselae, the 
causative agent of cat-scratch disease, has been reported as transmissible via ingestion in cats 
[120], though this finding was not supported by a subsequent investigation [121]. While these 
species provide examples of orally transmitted bacteria, other members of Rickttsiales, chiefly 
the TG members R. prowazekii and R. typhi, provide the most compelling comparisons. 
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1.3.1. Rickettsia prowazekii 
 Known as the “scourge of armies” Rickettsia prowazekii is of great historical importance 
as the louse-borne causative agent of epidemic typhus. It is estimated to have been the cause of 
death of up to 20% of Napoleon Bonaparte’s Grand Armée [122], three million people during the 
Russian Revolution of 1917 [123], and many innocents in concentration camps during World 
War II [124]. Although in 1995 it was thought to be functionally extinct, an outbreak occurred in 
1997 in the African country of Burundi after a civil war displaced a large percentage of the 
population into close-quartered refugee camps [125-127]. 
 Transmission of R. prowazekii to humans by the body louse Pedunculus humanus 
humanus (Pedunculus humanus corporis) occurs due to contact of infective lice feces or crushed 
lice with wounds (i.e. lice-feeding sites), conjunctiva, or mucus membranes, including contact 
with the airways via inhalation – a common route of infection for health care workers, as fecal 
matter can become particulate [128]. Frighteningly, the infective feces remain viable for up to 
100 days [128]. Humans are considered the reservoir host of R. prowazekii, as infection is fatal 
to lice; the bacteria rapidly replicate by binary fission, leading to rupture of the midgut epithelial 
cells and leakage of the bloodmeal, creating a “red louse” appearance [128]. The initial infection 
is treatable with doxycycline, however, a relapse known as Brill-Zinsser disease is known to 
occur, even years after the original course of disease [129]. In its recrudescent state epidemic 
typhus consists of bacteremia and may continue the transmission cycle, making the possibility of 
eradication extremely difficult [128]. This type of recrudescence has been proposed as an 
explanation for the inconsistent bacteremia associated with FBSF [33, 106]. 
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1.3.2. Rickettsia typhi 
 Similar to R. felis, Rickettsia typhi is found worldwide, causes a near identical menagerie 
of clinical signs and disease severity, and is transmitted by fleas. While its chief vector is the 
oriental rat flea Xenopsylla cheopis [130], R. typhi is also found in the cat flea [131] and may 
coinfect fleas along with R. felis [132]. Moreover, R. typhi and R. felis are transmitted vertically 
and horizontally among fleas in a similar manner [17] and neither is detrimental to the flea [130]. 
Transmission of R. typhi to humans results in murine typhus (endemic typhus) and occurs 
through several routes: an infective arthropod bite from fleas infected for more than 21 days 
[133], contamination of infective flea feces into wounds (i.e. flea-feeding sites) [134], exposure 
of oronasal mucosa including via inhalation [89], and contact with conjunctiva [133]. Infected 
fleas will begin shedding infective feces after 10 days [130] and their feces will remain viably 
infective for 10 days [112]. Considering the existing similarities and their ability to coinfect, the 
possibility of horizontal gene transfer between R. typhi and R. felis that could result in increased 
pathogenicity is not beyond the imagination. 
1.4. Summary 
Rickettsia felis has been identified as an emerging disease marked with the potential to 
become the next global epidemic. Predominantly transmitted by the cat flea, Ctenocephalides 
felis, it is the causative agent of flea-borne spotted fever in people and is an underrecognized 
etiologic agent of fever in animals. Once infected, fleas shed R. felis in their feces. Transmission 
from infected arthropods to vertebrates is known to occur via infectious flea bites and strong 
evidence suggests transmission occurs via inoculation of wound sites with infective flea feces, as 
is the case with typhus group rickettsiae which also have the potential for oronasal transmission 
via infective feces. The possibility that R. felis might also be transmitted via ingestion is further 
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supported by evidence of R. felis in the feces of both humans and animals. Therefore, our current 
study hypothesized that R. felis from culture and from infective cat flea feces would be infective 
to mice via ingestion.  
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 Rickettsia felis is a gram negative, obligate intracellular bacteria (class 
Alphaproteobacteria, order Rickettsiales) of the transitional group (TRG) of rickettsiae that is 
present mostly within its primary vector and reservoir host, the cat flea (Ctenocephalides felis) 
[8, 25]. Transmission within arthropods occurs both vertically and horizontally, suggesting that 
vertebrates play a role in the life cycle of R. felis [28, 38]. Further evidence for its association 
with vertebrates includes seropositivity in both animals and humans [25, 42]. Case series of 
disease in vertebrates that detected only R. felis by means of polymerase chain reaction (PCR) 
and/or serology have led to its characterization as the etiologic agent of flea-borne spotted fever 
(FBSF) in humans as well as a poorly recognized cause of fever in animals [25, 76, 105]. One 
known transmission route to vertebrates is via the bite of infected fleas during feeding [26], 
however, closely related members of the typhus group (TG) of rickettsiae, namely Rickettsia 
prowazekii and Rickettsia typhi, are shed in feces and can subsequently be transmitted in 
wounds, mucus membranes, conjunctiva, and oronasally via inhalation [89, 128, 133]. Our lab 
previously investigated the transmission of R. felis via intradermal inoculation to simulate fecal 
transmission in cutaneous wounds such as flea-feeding sites. The unpublished results indicate 
that the route is viable. Furthermore, there is evidence to support vertebrates are exposed to R. 
felis via ingestion, as R. felis has been detected in both human and ape feces [114, 115]. This is 
possibly due to the grooming habits of mammals and the poor hygiene of young children – the 
human group most infected with FBSF in Africa [105]. In the current study it is hypothesized 
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that ingestion of R. felis from culture and from infected cat flea feces will result in the 
transmission of R. felis to mice.  
2.2. Materials & Methods 
2.2.1. Source and Strain of Bacteria, Fleas, and Mice 
 The experiments performed utilized Rickettsia felis, Ctenocephalides felis, and BALB/c 
mice. Rickettsia felis strain LSU (Louisiana State University, passage 3) was cultured in Ixodes 
scapularis embryonic cells (ISE6) with L15B complete medium (L15B, 10% ∆FBS, and 10% 
tryptase phosphate broth at a pH of 6.8-7.0) in an incubator set at 32˚C and 5% CO2 as originally 
described by Pornwiroon et al [48]. Each week a concentrated smear (Figure 2) was made and 
stained with Diff-Quik to assess R. felis growth [48]. Fleas used were newly emerged Rickettsia-
uninfected cat fleas from Elward II (El-Labs, Soquel, CA). BALB/c mice were chosen, as 
previous work has described their ability to become infected with R. felis [135]. All mice were 
obtained from the Louisiana State University Division of Laboratory Animal Medicine for use as 
a murine model of mammalian disease; their gender was randomized, and they were juveniles 
with ages ranging from six to seven-week-old mice at the time of procurement.  
 
Figure 2. Rickettsia felis inside ISE6 cells. 1000x magnification oil-immersion, Diff-Quik stain. 
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2.2.2. Ethics Statement 
 This study was conducted in compliance with the Animal Welfare Act (9 CFR Ch. 1 
Subpart C 2.31 (c) 1-8), the Guide for the care and use of Agriculture Animals in Agricultural 
Research and Training (Ch. 1), and the Public Health Service Policy on Human Care and Use of 
Laboratory Animals (Section IV. B. (1-8)). Additionally, all animal-related research was 
conducted with approval of the LSU Institutional Animal Care and Use Committee (IACUC; 
Protocol Number: 15-115). 
2.2.3. Per Oral Administration of Rickettsia felis from Culture 
 For this experiment 15 test mice and three control mice were organized into three groups, 
each consisting of five test mice and one control mouse (Figure 3). Mice were caged according 
to gender and treatment status, keeping infected and control mice separated for the duration of 
the experiment. R. felis was cultured in ISE6 cells, enumerated with the backlight BacLight 
viability staining kit, and sucrose purified. Each test mouse received a solution containing 3.0 x 
106 R. felis organisms suspended in sucrose phosphate glutamate (SPG) buffer while each control 
mouse received an equivalent volume of SPG buffer only. This number was based on a study 
that indicated 3.0 x 106 was the upper range of R. felis per milligram of flea feces using high 
passage R. felis (passage 8) [113]. Therefore, this study was designed to simulate ingestion of 1 
mg of high passage R. felis-infected flea feces, aiming to recreate a natural exposure event 
wherein the dose of R. felis administered mimics the amount that may be ingested via grooming 
or poor hygiene in animals or humans, respectively. This experiment was performed in duplicate, 





Figure 3. Per oral administration of Rickettsia felis from culture. R. felis was grown in ISE6 
cells (culture flasks pictured top left, R. felis within ISE6 cells picture top right), quantified, 
sucrose purified, and then suspended in SPG buffer. Test mice were pipette-fed 3.0 x 106 R. felis 
organisms while control mice received an equivalent volume of SPG buffer only (central 
illustration). Mice were arranged into 3 test groups (bottom left), each with 1 control mouse 
(colored gray) and five test mice (colored black). Group 1 was sacrificed 1-day post ingestion, 
Group 2 at 7 DPI, and Group 3 at 14 DPI. A full necropsy was performed and heart, liver, spleen, 
stomach, and a jejunal segment were collected for gDNA extraction, RNA extraction, and 
histopathology. Blood was retrieved via intra-cardiac aspiration in 14 DPI mice. 
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2.2.4. Per Oral Administration of Rickettsia felis from Flea Feces 
 This experiment mirrored the first, consisting of 15 test mice and three control mice once 
again arranged into three groups, each with five test mice and one control mouse (Figure 4). 
Mice were caged by gender and treatment status, keeping infected and control mice separated for 
the duration of the experiment. R. felis was cultured in ISE6 cells, enumerated via the BacLight 
viability staining kit, purified, and then resuspended in 600 μL of heat-inactivated bovine blood. 
This infectious bloodmeal was provided to a colony of approximately 200 R. felis-uninfected 
fleas that had been previously withheld a bloodmeal for 6 hours. The fleas were allowed to feed 
on the infectious bloodmeal for 48 hours before it was changed for an uninfected bloodmeal, 
which the fleas received for the rest of the experiment. A control colony of fleas was also 
maintained in order to procure uninfected flea feces. 
 Flea feces collection coincided with cage changing and was performed once weekly for 
the duration of the experiment. Using a dissecting microscope, cage debris was examined and the 
flea feces were carefully separated from flea eggs, larvae, dead fleas, and dried blood. A small 
portion of flea feces was weighed and its gDNA was extracted using a Qiagen DNeasy Tissue 
Kit (Qiagen, Germantown, MD) per the instructions for tissue extractions then eluted with 25 μL 
of PCR-grade H2O. The extracted gDNA was tested via quantitative polymerase chain reaction 
(qPCR) using primers for rickettsial ompB [136] and the C. felis 18S rRNA gene [79]. 
Subsequently, the density of the R. felis load was identified and then used to calculate the weight 
of feces required to achieve 3.0 x 106 R. felis organisms. The flea feces were then suspended in 
SPG buffer and the correct volume pipette-fed to each test mouse. Control mice received a 
solution prepared using the same weight of R. felis-free feces collected from the control colony 
of fleas. These feces were verified R. felis-negative via qPCR. As with the first experiment, this 
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experiment was performed in duplicate, independently, with R. felis from different culture flasks, 
and different flea colonies during the second trial.  
 
Figure 4. Per oral administration of Rickettsia felis from flea feces. Colonies of cat fleas were 
fed an infectious bovine bloodmeal (top left). Their feces were isolated (top right) and proven to 
be R. felis positive via qPCR. A flea feces dose containing 3.0 x 106 R. felis organisms was 
calculated and suspended in SPG buffer. Test mice were pipette-fed infective flea feces and 
control mice were fed the same weight of qPCR-proven R. felis-free flea feces in an equivalent 
volume of SPG buffer (central illustration). Mice were arranged in 3 groups and sacrificed as in 
the previous experiment. Tissues and blood were also collected in the same way. 
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While the amount of R. felis each test mouse received remained constant across each trial, due to 
an inability to standardize the density of R. felis fleas excrete in their feces, the total weight of 
flea feces varied between trials. The variation is largely based on the amount of an infectious 
bloodmeal the colony ingests. 
2.2.5. Necropsy and Sample Collection 
 Mice were examined daily up until their sacrifice date for the duration of each 
experiment. Group 1 mice were sacrificed at 1-day post ingestion (DPI), Group 2 mice at 7 DPI, 
and Group 3 mice at 14 DPI. Mice were humanely euthanized individually, primarily via carbon 
dioxide chamber and secondarily via cervical spinal dislocation. Blood was collected from 
Group 3 mice via intra-cardiac aspiration, spun, and the serum removed. A full necropsy was 
performed on each mouse. Select organs were harvested, including heart, liver, spleen, stomach, 
and a jejunal segment, in that order to avoid gastrointestinal contamination. The organs were 
sectioned; one piece placed in a cassette and stored in 10% neutral buffered formalin, a second 
piece stored in a 1.7 mL Safe-Lock microcentrifuge tube for genomic DNA (gDNA) extraction, 
and a third piece stored in 1 mL of TRIzol for RNA extraction. The samples for gDNA 
extraction and serum samples were stored at -20 ˚C and the samples for RNA extraction were 
stored at -80 ˚C.  
2.2.6. Detection of Rickettsia felis in Tissues 
 Initial detection of R. felis in heart, liver, spleen, stomach, and intestine samples was 
performed via qPCR. First, the mouse tissues were homogenized. This process involved the 
addition of two stainless steel beads, proteinase K, and buffer ATL to each of the 1.7 mL Safe-
Lock microcentrifuge tubes. The samples were then run twice through the Tissue-Lyser (Qiagen, 
Valencia, CA) at 30 Hz for three minutes each cycle. Genomic DNA was then extracted per the 
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manufacturer’s instructions using the Qiagen DNeasy Tissue Kit, eluting with 25 μL PCR-grade 
H2O. Tissue samples were processed in batches of 30, which included all samples from a single 
timepoint of one experiment (i.e. 1 DPI R. felis from culture, replicate 1) and an environmental 
control containing only extraction reagents was included in every batch of extractions. Likewise, 
all samples from a timepoint were run on a single qPCR plate, along with the environmental 
control from the extraction process, a negative control consisting only of PCR-grade H2O and 
master mix, as well as two positive controls, one for R. felis and one for mouse. The qPCR was 
performed using a LightCycler 480 Real-Time PCR system (Roche), standard sets for both mice 
and R. felis, as well as primers for rickettsial ompB [136] and the mouse cfd [137]. Results were 
viewed as rickettsial copy numbers per sample and were considered positive if two of three 
replicates showed amplification before cycle 35, if negative and positive controls were correctly 
amplified, and if the standard curve was appropriate. 
 Select test samples, as well as their control sample counterparts, were chosen for 
histopathology and immunohistochemistry (IHC) based on qPCR results. Once formalin fixation 
was complete, these tissues were submitted for paraffin-embedding and were subsequently 
sectioned for hematoxylin and eosin (H&E) staining and IHC using polyclonal anti-Rickettsia 
antibodies diluted to 1/1000 as described previously by Grasperge et al [137]. All H&E and IHC 
slides were read and interpreted by an anatomic pathologist certified by the American College of 
Veterinary Pathologists. 
2.2.7. Detection of Rickettsia felis in Serum 
 Based on initial tissue sample qPCR findings, the serum of one mouse was selected for 
qPCR detection of R. felis as well as an indirect immunofluorescence assay for detection of an 
antibody response to R. felis. Genomic DNA was extracted from the serum and an environmental 
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control consisting only of extraction reagents using a Qiagen DNeasy Tissue Kit (Qiagen, 
Germantown, MD) and the protocol for gDNA extraction from non-nucleated blood. The sample 
was eluted with 25 μL of PCR-grade H2O and qPCR was performed using primers for rickettsial 
ompB and mouse cfd on a LightCycler 480 Real-Time PCR system (Roche). Samples were 
considered positive if two of three replicates showed amplification before cycle 35.  
The serum was also tested using an indirect immunofluorescence assay as described in 
previous studies [35]. R. felis from culture was fixed to a glass slide with 4% PFA and allowed to 
sit for 15 minutes. The slide was then washed three times five minutes apart with PBS. A 
blocking solution consisting of 3% BSA in PBS was applied and allowed to incubate for 1-hour 
at room temperature. Serum was diluted 1:100, applied to the slide, and allowed to sit at room 
temperature for one hour. Once again, the slide was washed three times five minutes apart with 
PBS. Finally, a secondary antibody (goat anti-mouse IgG conjugated to horseradish peroxidase 
diluted 1:1000 in blocking buffer) was applied and the slide was incubated at room temperature 
in the dark for 30 minutes. A mounting solution with added DAPI was then applied prior to 
cover-slipping. Samples were read using fluorescence microscopy (Leica). 
2.2.8. Assessment of Rickettsia felis Viability 
 PCR-positive tissue samples stored in TRIzol were further processed using the Bio-Rad 
iScript™ cDNA Synthesis Kit for reverse transcription quantitative PCR (RT-qPCR) to test the 
viability of R. felis organisms detected. First, the tissue samples were homogenized as previously 
described for gDNA extraction from tissue samples. Next, 200 μL of chloroform was added 
before vortexing and incubating the samples at room temperature for three minutes. The samples 
were then subjected to 15 minutes of centrifugation at 12,000 x g and 4˚C. The aqueous phase of 
the samples was pipetted-off, transferred to a new microcentrifuge tube, and 500 μL of 
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isopropanol was added. The samples were incubated overnight at -20˚C for increased RNA yield. 
Once precipitated, the samples were centrifuged at 12,000 x g and 4˚C for 10 minutes. The 
supernatant was pipetted-off, the pellet was washed with 1 mL of 75% ethanol, and the samples 
were vortexed and then centrifuged at 7,500 x g and 4˚C for 5 minutes. The supernatant was 
discarded and the RNA was allowed to air-dry for 10 minutes before resuspending with 25 μL of 
pre-warmed PCR-grade H2O. The samples were then incubated at 60˚C for 15 minutes. The 
samples were then subjected to two cycles of DNAse treatment, by combining with 5 μL 10x 
DNAse buffer, 1 μL Turbo DNAse, and 24 μL PCR-grade H2O before incubating at 37˚C for 30 
minutes. An additional 5.77 μL 10x DNAse buffer and 2 μL Turbo DNAse were added before 
being incubated at 37˚C for 30 minutes once again. The samples were then subjected to an RNA 
clean-up step as previously described [26]. A preliminary RT-qPCR was performed on all 
samples without the addition of iScript™ reverse transcriptase in order to establish the samples 
were free of DNA. Finally, the complementary DNA (cDNA) was generated from the samples 
with the addition of iScript™ reverse transcriptase as previously described [26], and RT-qPCR 
was performed on the samples, an environmental control from the RNA extraction process, a 
negative control consisting only of reagents and PCR-grade H2O, a negative control lacking 
iscript reverse transcriptase, and R. felis and mouse positive controls using rickettsial ompB and 
mouse cfd on a LightCycler 480 Real-Time PCR system (Roche). Samples were considered 
positive if two of three replicates showed amplification before cycle 35. 
2.3. Results 
2.3.1. Per Oral Administration of Rickettsia felis from Culture 
 Two replicates of the experiment were performed. All mice made it to their intended 
sacrifice dates without developing clinical signs of disease. Moreover, gross lesions were not 
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appreciated during the necropsy of any mouse. Genomic DNA was successfully extracted from 
the heart, liver, spleen, stomach, and intestines of each mouse and qPCR was successfully 
performed on all samples (Table 1). Of the five mice that had detectable levels of R. felis, three 
of them had two organs with detectable levels. Furthermore, all mice with detectable R. felis in 
more than one organ had detectable R. felis in their spleen. No mice had detectable levels of R. 
felis in either their stomach or intestine. The serum of an individual mouse that had detectable 
levels of R. felis in its heart and spleen was tested and found to be negative.  
Table 1. Detection of R. felis from culture via qPCR 
 
Quantitative PCR results of test mice from both replicates of the R. felis from culture model of 
ingestion. Detectable levels of R. felis occurring before PCR cycle 35 were considered positive. 
Two mice had detectable R. felis in their hearts, two in their livers, and four in their spleens. No 
mice had detectable levels of R. felis in their stomach or intestine. Samples marked with (*) 
indicate they came from a mouse with more than one positive sample. Percentages shown 
parenthetically. All samples from the control mice of both replicates were negative for R. felis. 
 
 All tissue samples of the two test mice with the highest R. felis densities (data not shown) 
and presence of R. felis in more than one organ were submitted for histopathology (Figure 5). 




Figure 5. Histopathology of mouse samples post-ingestion of R. felis from culture. All 
images to the right are of test mouse Rf13.1 (sacrificed 14 DPI) and images to the left are from 
the associated control mouse (hematoxylin and eosin stain, 100x). A, B. Heart. C, D. Liver. E, F. 
Spleen. G, H. Stomach. I, J Intestine. No evidence of disease is appreciated in any organ. Rf10.1 





liver and spleen and “Rf13.1” from the 14 DPI time-point with detectable R. felis in its heart and 
spleen. All tissue samples from the control mice associated with these test mice were submitted 
for comparison. Histopathology performed by a board-certified veterinary anatomic pathologist 
concluded that no evidence of disease was present in any samples.  
 Additionally, the qPCR positive organs of Rf10.1 and Rf13.1 were sectioned for 
immunohistochemistry (IHC) with a polyclonal anti-Rickettsia antibody diluted 1:1000 as 
previously described [137]. Of the four test organs analyzed with IHC, the spleen of Rf10.1 had 
few positively staining bacteria interpreted as R. felis (Figure 6). No other samples were 
considered positive.  
 
Figure 6. Anti-Rickettsia immunohistochemistry of mouse spleen post-ingestion of R. felis 
from culture. A. 400x photomicrograph of the spleen of the R. felis from culture 7DPI test 
mouse Rf10.1. R. felis organisms are observed both intracellularly and possibly in the 
extracellular space (red box). B. Inset with an expanded view of R. felis organisms in the red 





 An indirect immunofluorescence assay was performed on serum from Rf13.1 in order to 
determine if antibodies against R. felis were present. The serum was positive, as indicated by the 
fluorescent secondary antibody binding the mouse antibodies against R. felis which in turn bound 
a primary fixed layer of R. felis from culture (Figure 7). 
 
 
Figure 7. Indirect immunofluorescence assay of mouse serum post-ingestion of R. felis from 
culture. A. 1000x oil immersion photomicrograph of the test sample (serum from 14DPI R. felis 
from culture test mouse Rf13.1) demonstrates green fluorescence associated with binding of goat 
anti-mouse secondary antibody (dilution 1:1000) to mouse antibodies directed at R. felis. B. 
1000x oil immersion photomicrograph of the negative control lacks immunofluorescence. 
 
 
All tissue samples of Rf10.1 and Rf13.1, as well as the tissue samples of their associated 
control mice, were analyzed using RT-qPCR. The samples were initially processed without 
iscript ® reverse transcriptase to ensure no background amplification of rickettsial ompB was 
present. Once processed with iscript ® reverse transcriptase, no cDNA samples exhibited 
detectable levels of R. felis. 
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2.3.2. Per Oral Administration of Rickettsia felis from Flea Feces 
 As with the first experiment, two replicates of per oral administration of R. felis from flea 
feces were performed. Once again, all mice made it to their intended sacrifice dates without 
developing clinical signs of disease. Moreover, gross lesions were not appreciated during the 
necropsy of any mouse. Genomic DNA was successfully extracted from the heart, liver, spleen, 
stomach, and intestines of each mouse and qPCR was successfully performed on all samples 
(Table 2). As all samples were negative, no additional tests were performed. 
 
Table 2. Detection of R. felis from flea feces via qPCR 
 
Quantitative PCR results of test mice from both replicates of the R. felis from flea feces model of 
ingestion. No samples exhibited detectable levels of R. felis occurring before PCR cycle 35. The 




CHAPTER 3. DISCUSSION & FUTURE DIRECTIONS  
 
 Owing to its similarities with typhus group Rickettsia, Rickettsia felis has been identified 
as a pathogen that is potentially transmitted in flea feces by contact with mucus membranes. The 
supporting evidence for this route of infection includes the tropism of R. felis for flea midgut 
epithelial cells, Malpighian tubules, and rectal ampulla [40], proof that fleas shed viable R. felis 
organisms in their feces, and the discovery of R. felis in mammalian feces, suggesting alimentary 
passage [114, 115]. Theoretically, this route of transmission may also account for the 
predilection of young children in sub-Saharan Africa to contract R. felis-induced flea-borne 
spotted fever (FBSF) [105], due to frequent oral exposure. Along those lines, mammals such as 
cats and non-human primates with meticulous grooming habits would stand to have 
exceptionally increased risk for oral exposure to infective flea feces, potentially contributing to 
disease as a poorly characterized cause of fever. 
 Interestingly, several putative genes have been identified that could ameliorate the role of 
R. felis as a pathogen transmissible via ingestion. Chiefly, R. felis contains a hyaluronidase that 
has been shown to be highly similar to that of Clostridium perfringens, one of the most common 
causes of food poisoning largely due to the actions of its hyaluronidase on the gastrointestinal 
epithelial cells. Also known as a “spreading factor,” hyaluronidase is proposed as a means for 
degrading polysaccharides such as those holding mammalian tissues together. Additionally, R. 
felis contains an ortholog (Rf0371) to RickA of Rickettsia conorii which is tied to mobility via 
actin polymerization [46]. Best demonstrated by Listeria monocytogenes, actin polymerization is 
an effective means for entering cells by force subsequent to the creation of a posterior actin trail. 
Ogata et al were [46] able to visualize R. felis actin filaments and differentiate them from host 
34 
 
cell stress fibers with immunofluorescence microscopy, providing further support for functional 
actin mobility in R. felis. 
 In light of this mounting support, we hypothesized that R. felis would be infective to 
vertebrates via ingestion. Specifically, we designed sister experiments to test this theory with R. 
felis from culture as well as R. felis in cat flea feces. We utilized BALB/c mice as a model of 
vertebrate disease in order to compare results with a previous transmission study investigating 
the infectivity of R. felis-laden cat flea feces via dermal inoculation [113]. Likewise, our 
infectious dose of 3.0 x 106 R. felis organisms was chosen to represent the upper range of R. 
felis-burden of 1 milligram of cat flea feces [113], approximating the amount that a small child 
or other small mammal could be expected to ingest through indiscriminate oral exposure or 
grooming behaviors.  
 Our results indicate that R. felis is capable of infecting mice via ingestion, as determined 
by positive qPCR findings in the R. felis from culture experiment. Specifically, 5 out of 30 test 
mice orally administered R. felis from culture had rickettsial DNA at sites distant from the 
gastrointestinal tract, indicating an infection rate of 17%. Of the infected mice, we recovered 
rickettsial ompB in 80% of spleens (4/5 mice) and 40% of hearts and livers (2/5 mice each). 
Moreover, the majority of mice that were infected exhibited more than one organ with detectable 
levels of R. felis (3/5 mice). Furthermore, R. felis detected via qPCR was additionally 
corroborated by the positive staining of low numbers of R. felis organisms with anti-Rickettsia 
immunohistochemistry in the spleen of an individual mouse. While detection of R. felis in 
mammalian viscera has been previously demonstrated [26, 95, 138], the ability of ingested R. 
felis to disseminate to distant organs is a novel finding with broad implications for how R. felis is 
potentially transmitted to, among, and within vertebrate hosts.  
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Transmission of R. felis to vertebrate hosts has been established through infectious cat 
flea bites [26] and intradermal inoculation of infective flea feces [113]. Here we have been able 
to demonstrate alimentary transmission of R. felis from culture, though our attempts to transmit 
R. felis to mice via ingestion of infective cat flea feces failed. While no conclusions may be 
drawn regarding the infectivity of R. felis in cat flea feces via ingestion in mice, we can speculate 
on the ways in which mammals might come to ingest R. felis outside of cat flea feces. One 
possible route would be via ingestion of whole cat fleas – or other arthropods – infected with R. 
felis. This model of transmission was explored with negative results by Foil et al [121] as a 
means for transmission of Bartonella henselae in cats, though to the author’s knowledge this 
route has yet to be explored for R. felis. Transmission of R. felis may also occur via ingestion of 
cutaneous R. felis, as Mediannikov et al [108] demonstrated that R. felis may be ubiquitous in 
environments of high prevalence, such as parts of Senegal. Specifically, cotton swabs of non-
diseased skin of Senegalese people revealed detectable levels of R. felis via qPCR [108]. Thus, 
through routine grooming or indiscriminate oral habits, animals and young children might come 
in contact with free R. felis organisms; whether or not these organisms are viable remains to be 
seen. 
The possibility of R. felis transmission directly between vertebrates has been poorly 
explored and not yet proven, however, if transmission of ingested material can result in infection, 
additional avenues of exposure arise. One route might be the ingestion of infectious feces of 
other vertebrates. Some species, such as dogs, regularly exhibit coprophagia behavior, and 
subsequently might become infected via a fecal-oral route. Though R. felis has been shown to be 
viable in flea feces, viability of R. felis in vertebrate feces has yet to be established. Another 
potential route of transmission between vertebrates is via ingestion of other vertebrate organisms 
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infected with R. felis, as suggested by De Nys et al [139] regarding the presence of R. felis in the 
feces of non-human primates. This route would be especially applicable to cats due to their 
predatory nature and is further supported by evidence that many species of small mammals can 
be infected with R. felis [73, 74, 77, 138].   
The current study also raises questions regarding the dissemination of R. felis within 
vertebrate hosts. Our results suggest that R. felis was not only able to survive the extreme acidity 
of the stomach, it was able to successfully contend with several innate barriers of the intestines, 
including mucus, anti-microbial peptides, and commensal bacteria well-adapted to monopolizing 
available space and resources [140]. The mucus present within the gastrointestinal tract variably 
consists of two specialized layers: a thin, easily-removed top layer present throughout the 
gastrointestinal tract and a dense bottom layer firmly adhered to the epithelial cells that is absent 
only in the small intestines [141]. One means of breaking through the mucus is via glycosidases, 
enzymes necessary for the degradation of mucin oligosaccharides [140], which have not been 
attributed to R. felis at this time. Therefore, unless the single mucin layer of the small intestine is 
removed through pre-existing disease, it is likely that R. felis requires an alternative route to 
infection. One option would be the microfold cells (M-cells) located throughout the 
gastrointestinal tract in mucosal-associated lymphoid tissues (MALT) and in the Peyer’s patches 
of the small intestine. As these cells are uniquely uncovered by mucus at all times, they may 
provide a consistent surface by which R. felis might attach through the actions of its sca genes, 
including ompB. Furthermore, the M-cells might provide critical access to cells of the immune 
system, chiefly macrophages, for which R. felis has known tropism [142]. Subsequently, as the 
infected macrophages circulate, R. felis might be able to disseminate to distant sites, such as the 
spleen, liver, or heart. Alternatively, R. felis has also demonstrated tropism for endothelial cells 
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[142]. Therefore, if the gastrointestinal tract has pre-existing ulcerative disease, R. felis might 
gain easy access to these cells and move cell-to-cell via actin polymerization in a manner similar 
to Listeria monocytogenes, or gain entry to the bloodstream for metastatic spread, again leading 
to R. felis presence in distant organs. Lastly, R. felis might employ hyaluronidase to burrow its 
way to endothelial cells or macrophages, a process that may even occur in the oral cavity or 
esophagus. 
While our study demonstrates the ability of R. felis to infect mice via ingestion, it notably 
does so without inducing an inflammatory response. All sections of test mice tissue positive for 
R. felis via qPCR lack overt histopathologic changes as compared to control mice sections. 
Furthermore, the splenic tissue positive via immunohistochemistry (IHC) for R. felis 
demonstrates a complete lack of inflammation at the site of the bacteria. This finding suggests 
that R. felis is capable of effectively evading the immune system, a trait shared with other 
obligate intracellular bacteria. Considering its low numbers despite a lack of immune pressure, it 
is plausible that R. felis bides its time and replicates slowly in infected mammalian cells, 
potentially further avoiding notice by the host immune system. This would explain the relatively 
low number of organisms detected by all methods in infected mice throughout all time-points. 
Additionally, this would explain the negative RT-qPCR results from tissues that were positive 
for R. felis DNA via qPCR, as the low total number of organisms might preclude detection. 
Furthermore, even though RT-qPCR was negative, the R. felis observed are thought to be viable 
considering their transit from the gastrointestinal tract to a distant site of infection. This is 
supported by the finding that R. felis from IHC were observed in groups, suggesting some 
replication did occur. 
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Although the infected test mice failed to mount a cell-mediated immune response, we 
demonstrated the presence of a humoral response in the individual infected mouse we tested via 
an indirect immunofluorescence assay. This finding is in line with many earlier studies that have 
documented antibodies to R. felis in vertebrates [42, 85, 96, 97]. Humoral responses are 
ineffective at eliminating intracellular bacteria, in contrast to cell-mediated responses that deploy 
cytotoxic T-lymphocytes. Interestingly, some bacteria are capable of modulating the host 
immune system in order to direct the host towards an ineffective immune response, thus 
increasing odds of survival [143]. While it is unknown at this time whether R. felis is capable of 
this, it would help to explain the observed lack of a cell-mediated immune response as well as 
the inconsistent presence of humoral responses observed in the literature [33, 106].   
Further studies are needed to better characterize all aspects of transmission of R. felis to 
vertebrates via ingestion. Here we tested a single dose and strain of R. felis in a single strain of 
mice, leaving much to be elucidated. While we were unsuccessful at transmitting R. felis to mice 
via ingestion of infective flea feces, the dose used is still relatively low depending on how much 
infective flea feces is consumed. Our model is based on consumption of 1 mg of flea feces with 
high passage R. felis, though it is conceivable that both animals and young children could 
consume more flea feces by weight or that the R. felis may be of a lower passage. Furthermore, 
mammalian feces – particularly from animals and people with documented R. felis infection – 
should continue to be inspected for R. felis, not only via qPCR but also with RT-qPCR to 
determine R. felis viability. If such feces are found to contain viable R. felis, increased measures 
protecting both animals and people from exposure could then be employed. Additionally, the 
pathogenesis of R. felis via ingestion requires further investigation. While we have provided 
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several possibilities based on the known genes of R. felis, the function of these genes remains 
putative in in vivo mammalian cells and must be further characterized.  
It is important to note the many variables at play with disease transmission, including 
rickettsial strain, type of arthropod vector, type of mammalian target, and route of infection. 
Each of these factors may affect the outcome of transmission, whether or not disease ensues, and 
the severity of such disease. Considering this complexity, it is not surprising that Koch’s 
postulates have gone unfulfilled. Our study identified that organs infected with R. felis exhibit a 
low burden up to 14 DPI, therefore highly efficient methods of recovering these bacteria, 
potentially incorporating a host cell lysis step and separation via flow cytometry, might improve 
chances for culturing R. felis from infected animals. 
In conclusion, the present study has demonstrated that ingestion of R. felis serves as a 
viable route of transmission and subsequent infection in mice. Additionally, this study has 
provided evidence that R. felis is capable of disseminating to distant organs from the starting 
point of the gastrointestinal tract and that it can do so without inducing inflammation. We have 
also provided further evidence of a humoral response post-infection with R. felis. Our findings 
have increased the plausibility of several additional avenues of transmission, including 
transmission between vertebrates via ingestion of infective vertebrate tissues or infective 
vertebrate feces. Moreover, we have posited theories detailing how R. felis is able to escape the 
gastrointestinal tract and metastasize. All considered, this study has expanded the current 
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